Clinical trial
Use of Cidofovir for Recurrent Respiratory Papillomatosis
NCT00205374 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00205374 |
|---|---|
| Title | Use of Cidofovir for Recurrent Respiratory Papillomatosis |
| Official title | Use of Cidofovir Injection in the Treatment of Recurrent Respiratory Papillomatosis." |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Recurrent Respiratory Papillomatosis |
| Intervention type | Drug |
| Interventions | Cidofovir, Placebo |
| Enrollment | 19 |
| Start date | Nov 1, 1999 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 26, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: